What dose do I start at, and how fast do I move up?
Approved GLP-1 medications are designed to start at a low dose and step up gradually, which gives your body time to adjust. The exact starting point, the size of each step, and how long you stay at each one are set by the FDA prescribing label for that specific medication and by the prescriber who knows your history, not by an app. If you want the official schedule, it lives in the prescribing label for your medication, and your provider is the one who decides what is right for you. And if anything gets sold to you with no prescription and no titration plan, treat that as a reason to slow down and ask your provider questions.
- Approved GLP-1 medications such as semaglutide and tirzepatide are titrated, meaning the dose is stepped up gradually rather than started at full strength.
- The official titration schedules live in the FDA prescribing labels (Wegovy, Zepbound, Mounjaro), which your prescriber uses to set your plan.
- Retatrutide is investigational and not FDA-approved, so it has only been studied in clinical trials and there is no established schedule for general use.
- The semaglutide schedule comes from the Wegovy prescribing label and the STEP 1 trial (Wilding et al., NEJM 2021).
- The tirzepatide schedule comes from the Zepbound and Mounjaro prescribing labels and the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022).
Your guided peptide companion.
PRTCL walks beginners through their first peptide with confidence - guided reconstitution, syringe unit math from your own numbers, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.
- · Guided walkthrough for your first dose
- · Your vial and your dose, converted into syringe units
- · Vial inventory and dose log tracking
- · A library where every claim cites its source
Free to start.